PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
Hagens Berman reminds investors in PROCEPT (NASDAQ: PRCT) of the September 22, 2026 lead plaintiff deadline in an ongoing securities class action.
The firm encourages investors who suffered substantial losses to submit your losses now.
| Class Period: Feb. 28, 2024 – Feb. 25, 2026 | |
| Visit: www.hbsslaw.com/prct | |
| Contact the Firm Now: | PRCT@hbsslaw.com |
844-916-0895 |
|
| Video: youtu.be/N5u0rLr0QmA |
What does the PRCT Class Action allege?
The lawsuit alleges that defendants concealed an extensive, undisclosed bulk-order discount program. This program allegedly inflated sales by incentivizing customers to purchase handpieces far exceeding actual procedure demand.
The truth emerged through a series of disclosures, culminating on February 25, 2026, when PROCEPT reported disappointing Q4 results, revealed a massive inventory overhang, and announced the elimination of the discount program, causing PRCT stock to drop.
What is Hagens Berman investigating?
“We’re focused on whether PROCEPT deceptively pulled-in sales from future quarters,” said Reed Kathrein, a Hagens Berman partner.
What can PRCT Investors Do?
If you invested in PROCEPT during the Class Period and suffered losses, you have until September 22, 2026, to ask the court to appoint you as lead plaintiff. Contact the firm now to discuss your rights.
Whistleblowers: Persons with non-public information regarding PROCEPT should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email PRCT@hbsslaw.com.
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300, Berkeley, CA 94710, 844-916-0895, PRCT@hbsslaw.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260917795065/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
33 Undervalued Stocks to Buy Before the Market Shifts Again
United States